Concentra Group Holdings Hits New 52-Week High at $30.89

Concentra Group Holdings Parent, Inc. has reached a significant milestone by hitting a new 52-week high of USD 30.89 on July 1, 2026. This achievement highlights the stock's upward momentum within the Pharmaceuticals & Biotechnology sector, where it operates as a small-cap company with a market capitalization of USD 2,717 million. Over the past year, Concentra Group Holdings has demonstrated a performance that outpaces the S&P 500, with a notable increase of 20.74%. The company's price-to-earnings (P/E) ratio stands at 15.00, indicating its valuation relative to earnings. However, it is important to note that the company has a high debt-to-equity ratio of 4.01, which may raise considerations regarding its financial leverage. Despite a dividend yield of 0.00% and a price-to-book ratio of 6.91, the stock's recent performance reflects a positive trend in the market. The previous 52-week low was recorded at USD 18.55, marking a significant recovery and growth trajectory for Concentra Group Holdings Parent, Inc.